The articles mention Myanmar bureaucracy as an important challenge that the company will have to navigate. From your conversations, do you think this will be much of an issue?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025